COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.
COVID-19
inflammatory bowel disease
long term
outcomes
Journal
Therapeutic advances in gastroenterology
ISSN: 1756-283X
Titre abrégé: Therap Adv Gastroenterol
Pays: England
ID NLM: 101478893
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
05
2022
accepted:
20
09
2022
entrez:
9
11
2022
pubmed:
10
11
2022
medline:
10
11
2022
Statut:
epublish
Résumé
Inflammatory bowel disease (IBD) is not associated with worse coronavirus disease 2019 (COVID-19) outcomes. However, data are lacking regarding the long-term impact of severe acute respiratory syndrome coronavirus 2 infection on the disease course of IBD. We aimed to investigate the effect of COVID-19 on long-term outcomes of IBD. We performed a multicenter case-control study of patients with IBD and COVID-19 between February 2020 and December 2020. Cases and controls were individuals with IBD with presence or absence, respectively, of COVID-19-related symptoms and confirmatory testing. The primary composite outcome was IBD-related hospitalization or surgery. We identified 251 cases [ulcerative colitis ( In this case-control study, COVID-19 did not have a long-term impact on the disease course of IBD. However, severe COVID-19 was numerically associated with worse IBD outcomes, underscoring the continued importance of risk mitigation and prevention strategies for patients with IBD during the ongoing COVID-19 pandemic.
Sections du résumé
Background
UNASSIGNED
Inflammatory bowel disease (IBD) is not associated with worse coronavirus disease 2019 (COVID-19) outcomes. However, data are lacking regarding the long-term impact of severe acute respiratory syndrome coronavirus 2 infection on the disease course of IBD.
Objectives
UNASSIGNED
We aimed to investigate the effect of COVID-19 on long-term outcomes of IBD.
Design
UNASSIGNED
We performed a multicenter case-control study of patients with IBD and COVID-19 between February 2020 and December 2020.
Methods
UNASSIGNED
Cases and controls were individuals with IBD with presence or absence, respectively, of COVID-19-related symptoms and confirmatory testing. The primary composite outcome was IBD-related hospitalization or surgery.
Results
UNASSIGNED
We identified 251 cases [ulcerative colitis (
Conclusion
UNASSIGNED
In this case-control study, COVID-19 did not have a long-term impact on the disease course of IBD. However, severe COVID-19 was numerically associated with worse IBD outcomes, underscoring the continued importance of risk mitigation and prevention strategies for patients with IBD during the ongoing COVID-19 pandemic.
Identifiants
pubmed: 36348637
doi: 10.1177/17562848221132363
pii: 10.1177_17562848221132363
pmc: PMC9637830
doi:
Types de publication
Journal Article
Langues
eng
Pagination
17562848221132363Informations de copyright
© The Author(s), 2022.
Références
J Clin Med. 2022 Jan 14;11(2):
pubmed: 35054116
Inflamm Bowel Dis. 2022 Oct 3;28(10):1618-1622
pubmed: 35325137
Clin Gastroenterol Hepatol. 2021 Nov;19(11):2312-2314.e3
pubmed: 34102340
Med Sci Monit. 2020 Nov 01;26:e928996
pubmed: 33177481
Nat Immunol. 2022 Feb;23(2):210-216
pubmed: 35027728
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2134-2135
pubmed: 32360811
Sci Rep. 2021 Nov 23;11(1):22777
pubmed: 34815503
Arch Intern Med. 2009 Dec 14;169(22):2142-7
pubmed: 20008700
Mayo Clin Proc. 2021 Jul;96(7):1782-1791
pubmed: 34218857
Inflamm Bowel Dis. 2021 Apr 15;27(5):662-666
pubmed: 32578843
Gut. 2021 Apr;70(4):725-732
pubmed: 33082265
Gastroenterology. 2020 Jul;159(1):6-13.e6
pubmed: 32272113
Aliment Pharmacol Ther. 2021 Jul;54(2):160-166
pubmed: 34110040
Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1263-e1282
pubmed: 34954338
N Engl J Med. 2020 Dec 3;383(23):2255-2273
pubmed: 33264547
Gastroenterology. 2020 Oct;159(4):1541-1544.e2
pubmed: 32479824
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Inflamm Bowel Dis. 2020 Sep 18;26(10):e132-e133
pubmed: 32619003
Nat Immunol. 2022 Feb;23(2):194-202
pubmed: 35105985
Front Med (Lausanne). 2022 Jan 12;8:819557
pubmed: 35096910
Gastroenterology. 2020 Aug;159(2):481-491.e3
pubmed: 32425234
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
J Crohns Colitis. 2022 Jun 24;16(5):757-767
pubmed: 34755858
Gastroenterology. 2020 Oct;159(4):1575-1578.e4
pubmed: 32522507
Respirology. 2010 Apr;15(3):543-50
pubmed: 20337995
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Scand J Immunol. 2021 Mar;93(3):e12989
pubmed: 33113222
J Crohns Colitis. 2021 Nov 8;15(11):1877-1884
pubmed: 33884425